Provider QP74-23 Commercial Pharmacy Benefit Exclusion for Abilify Asimtufii®, Adstiladrin®, Brixadi™, Glydo®, lidocaine 2%, Roctavian™, and Uzedy™ Read More
Provider QP75-23 MHCP Pharmacy Benefit Exclusion for Adstiladrin®, Brixadi™, and Roctavian™ Read More
Provider P60-23 Home Health Agencies are Required to Provide Minnesota Home Care Bill of Rights for Clients Read More
Provider P61-23 Inpatient Hospital Admission Prior Authorization Removed for Medicare Advantage; Pre-Admission Notification Required Read More
Provider P62-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Medical Oncology Drug Prior Authorization Updates Read More
Provider P63-23 New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective November 6, 2023 Read More
Provider P65-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Radiation Oncology Clinical Guideline Updates Read More
Provider P66-23 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama Read More
